We found worse scores among patients who developed cognitive impairment in the UPSIT, RBDSQ, Geriatric Depression Scale, MDS-UPDRS-III, amyloid-β:tau ratio, and axial gait score. This evidence concerns the gene MAPT and depressive symptom measurement.